MacroGenics | MGNX - Należności Handlowe





Należności Handlowe Zmiana Data
AbbVie USD 12.48B 110M 2026-03
Amgen USD 10.23B 1.09B 2026-06
AstraZeneca USD 18.86B 972M 2026-06
Biogen USD 1.79B 76.6M 2026-03
Bristol-Myers Squibb USD 13.83B 535M 2026-06
Daiichi Sankyo JPY 676.92B 19.03B 2026-06
Eli Lilly USD 23.48B 2.3B 2026-06
Genmab DKK 1.22B 192M 2026-06
Geron USD 44.1M 4.87M 2026-03
Gilead Sciences USD 5.06B 314M 2026-06
J&J USD 22.54B 1.21B 2026-03
Karyopharm Therapeutics USD 23.36M 2.82M 2026-03
MacroGenics USD 10.42M 2.95M 2026-03
Merck USD 12.21B 435M 2026-03
Pfizer USD 16.19B 19M 2026-06
Puma Biotechnology USD 28.1M 3.52M 2024-06
Regeneron Pharmaceuticals USD 6.57B 834.4M 2026-06
Roche Holding CHF 13.34B 1.44B 2026-06
Xencor USD 42.23M 30.23M 2026-06